Bioxytran, Inc.
BIXT
$0.07
$0.002.21%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.42% | 36.05% | 31.47% | 52.64% | 37.75% |
| Total Depreciation and Amortization | 30.68% | -3.30% | -20.41% | -4.82% | 62.96% |
| Total Amortization of Deferred Charges | 1,032.36% | 2,059.33% | 94.43% | 94.43% | -84.55% |
| Total Other Non-Cash Items | 0.84% | -37.53% | 22.61% | 162.90% | -5.52% |
| Change in Net Operating Assets | -52.88% | -59.63% | -53.06% | -73.19% | -29.31% |
| Cash from Operations | 29.08% | 54.90% | 61.75% | 73.01% | 58.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.75% | -54.88% | 51.32% | 36.34% | 42.96% |
| Cash from Investing | -27.75% | -54.88% | 51.32% | 36.34% | 42.96% |
| Total Debt Issued | 11.95% | 178.38% | 121.71% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.59% | -100.00% | -88.55% | -88.55% | -90.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21.36% | -49.82% | -52.73% | -60.65% | -44.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.92% | 67.51% | 96.11% | 92.24% | 84.48% |